O'Neill takes helm of new structural heart unit at Henry Ford

William W. O'Neill, MD, has been appointed medical director of the new Center for Structural Heart Disease at Henry Ford Hospital in Detroit. He will begin his new position on July 31.

O'Neill has been working on new catheter-based treatments of structural heart disease, and performed the first aortic valve replacement through a catheter in the U.S. in 2005.  

He has worked in academic and teaching hospitals for nearly 30 years, and to date, is the author of more than 300 peer-reviewed articles and abstracts published in medical literature. He was a founding member of the American Board of Internal Medicine interventional cardiology board, which certifies interventional cardiologists.

Prior to this appointment, he was the executive dean for research, research training and innovative medicine, and CEO for research at University of Miami Miller School of Medicine. Previous positions include corporate chief of cardiology at William Beaumont Hospital in Troy, Mich., as well as director of the cardiac cath lab and associate professor of medicine at the University of Michigan Hospital in Ann Arbor.

A graduate of Wayne State University School of Medicine in Detroit, where he was a resident, O'Neill completed a cardiology fellowship at the University of Michigan Hospital.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.